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Adrenomedullin (ADM) functions as a survival factor against hypoxic cell death. However, molecular
mechanisms underlying the cell survival pathway remain largely unknown. In this report, we
showed that ADM suppressed reactive oxygen species (ROS) increase by inhibiting reduction of glu-
tathione (GSH) level in hypoxia/reoxygenation (H/R) injury, and increased the activities of glutathi-
one peroxidase and reductase. In addition, ADM maintained total and active reduced thioredoxin
(Trx) levels against H/R. We also found that ADM blocked nuclear translocation of Trx induced by
H/R. The results of the present study show that ADM regulates cellular ROS levels via the GSH and
Trx system.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction Hypoxia/reoxygenation (H/R) is not only a common cause ofAdrenomedullin (ADM), initially identiﬁed in human pheochro-
mocytoma, is a member of the calcitonin gene-related peptide
family with properties ranging from vasodilation to inhibition of
apoptosis [1,2], and is expressed in a variety of cells including
endothelial cells, ﬁbroblasts, and cardiomyocytes [3]. ADM is syn-
thesized as a biologically inactive precursor protein of 185 amino
acid residues, converted to a Gly-extended intermediate form,
and released as a mature amide structure peptide of 52 amino acid
residues [4]. Upon secretion, it exerts its multifunctional autocrine/
paracrine effects through G-protein-coupled calcitonin receptor-
like receptor (CRLR) [5]. Recently, it was reported that ADM pro-
tects against cell death induced by various cellular stresses such
as mannitol or hypoxia [6,7]. Although signalling processes seemed
to be modulated and explained by the up-regulation of anti-apop-
totic Bcl-2 proteins or activation of phosphatidylinositol-3-kinase/
Akt pathway [6,7], the molecular mechanisms underlying ADM’s
role as a survival factor against hypoxia remain unknown.chemical Societies. Published by E
tonin receptor-like receptor;
in isothiocyanate; c-GCL, c-
e; GR, glutathione reductase;
, hypoxia-inducible factor-1
genase; ROS, reactive oxygen
; TrxR, thioredoxin reductasecell injury, but also a clinically important phenomenon with path-
ological implications in disease processes, including lung injury
after severe shock or lung transplantation [8]. Although complex
signalling networks are involved in cell death resulting from H/R
injury, reactive oxygen species (ROS) and their cytotoxic effects
are believed to play a central role in H/R-induced cell death.
ROS generated during H/R injury trigger various cytotoxic effects
including DNA damage, lipid peroxidation, mitochondrial perme-
ability transition, and pore formation in membranes [9,10]. There-
fore, to protect against ROS-mediated cell injury, cells must
possess various mechanisms to regulate cellular redox status.
Generally, cellular redox is controlled by the thioredoxin (Trx)
and glutathione (GSH) systems. They are two of the major small
molecular weight thiol-containing compounds that scavenge
harmful ROS [9].
Although it is well accepted that ADM acts as a survival factor to
inhibit cell death from hypoxic injury, the role of ADM in regula-
tion of cellular redox status has not been studied. The purpose of
this work was to investigate the molecular mechanisms of ADM
in protecting against H/R-induced cell death in association with
the ROS scavenging systems. In this report we determined altera-
tions of GSH and Trx levels, enzyme activities of major ROS scav-
enging systems such as catalase, GSH peroxidase, and superoxide
dismutase (SOD), and redox status of Trx in response to H/R injury.
This study is the ﬁrst report showing that ADMmodulates the thiol
redox system for protection against H/R injury.lsevier B.V. All rights reserved.
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2.1. Cell culture, H/R conditions, and reagents
The A549 cells, the human epithelial carcinoma cell line of the
lung, and human umbilical vein endothelial cells (HUVEC) were
purchased from American Type Culture Collection (Rockville, MD,
USA). A549 cells were cultured in RPMI medium containing 10%
FBS under 5% CO2. HUVEC cells were grown in MEM with 15%
FBS. For H/R condition, cells were exposed to 0.2% O2 balanced with
5% CO2/94.8% N2 in a hypoxic chamber (Invivo2, Ruskinn, UK) for
the indicated times, followed by reoxygenation in normal culture
conditions for 1 h or varying durations. The human complete
ADM, ADM receptor antagonist peptide (ADM22-52, ADMA), and
goat anti-human ADM antibody were purchased from Bachem
(Bubendorf, Switzerland). Anti-glutathione peroxidase and anti-
CRLR, anti-Trx, and anti-Trx reductase antibodies were obtained
from Abcam (Cambridge, UK), Santa Cruz Biotechnology (CA,
USA), and Upstate Biotechnology (NY, USA), respectively. All other
reagents were obtained from Sigma–Aldrich Inc. (St. Louis, MO,
USA), unless otherwise speciﬁed.
2.2. Reverse transcription-polymerase chain reaction (RT-PCR) of CRLR
Total RNA of A549 cells was extracted using TRIzol reagent. First
strand cDNA was synthesized from 5 lg of total RNA using oligo-
dT primer and Moloney murine leukemia virus reverse transcrip-
tase (Life Technology Inc., Rockville, MD) and subjected to PCR
with the primers of CRLR (forward; 50-TGC TCT GTG AAG GCA
TTT AC-30, reverse; 50-CAG AAT TGC TTG AAC CTC TC-30). The PCR
condition was 94 C for 10 min followed by 32 cycles of 94 C for
30 s, 60 C for 30 s, and 72 C for 90 s.
2.3. Cell death and lactate dehydrogenase (LDH) assays
Cell death was monitored by the trypan blue exclusion method.
Membrane integrity was determined by measuring the leakage of
LDH into the culture medium. Brieﬂy, culture medium and cells
were harvested and centrifuged at 900g for 5 min. The activity
of LDH was determined spectrophotometrically from the changes
in absorbance at 560 nm, using 0.18 mMNADH and 0.72 mM pyru-
vate as substrates in 50 mM phosphate buffer.
2.4. Western and redox Western blot analysis
Western blot analysis on CRLR was performed as described pre-
viously [11]. The redox state of Trx was determined by a Western
blot method in which the electrophoresis was performed under na-
tive conditions to facilitate separation of differently charged forms
of Trx [12]. Cells were lysed by hypotonic lysis buffer (10 mM
HEPES, pH 7.8, 10 mM KCl, 2 mM MgCl2, 0.1 mM EDTA, 0.2 mM
NaF, 0.2 mM Na3VO46H2O) with the protease inhibitors. Proteins
were suspended in guanidine-Tris solution (6 M guanidine–HCl,
50 mM Tris, pH 8.3, 3 mM EDTA, 0.5% Triton-X100) supplemented
with 50 mM iodoacetic acid to allow separation of Trx according to
redox state as described previously [13]. Derivatized proteins were
separated by native polyacrylamide gel electrophoresis (PAGE),
transferred to membrane, probed with anti-Trx antibody, and visu-
alized using a chemiluminescence system (Amersham Pharmacia
Biotech., NJ, USA).
2.5. Cell fractionation and immunoblotting
A549 cells were subjected to a H/R condition with or without
ADM. The harvested cells were washed and homogenized in50 mM phosphate homogenate buffer containing protease inhibi-
tors. The nuclear fraction was obtained by centrifugation at
900g for 10 min. The cytosolic fraction was obtained from nu-
cleus-free extract by centrifugation at 150 000g for 1 h. The pro-
teins obtained from nuclear or cytosolic fractions were separated
using 12% SDS–polyacrylamide gels and transferred to nitrocellu-
lose membranes. The blots were then incubated with anti-Trx anti-
body, followed by detection with a chemiluminescence system.
2.6. GSH assay
GSH contents were determined as described previously [14].
Brieﬂy, cells suspended in salt medium (117.6 mM NaCl, 5.4 mM
KCl, 1.8 mM CaCl2, 0.8 mM MgSO4, 44 mM NaHCO3, 0.91 mM
NaH2PO4, pH 7.4) were ﬁxed with 5% 5-sulfosalicylic acid and lysed
by freezing and thawing. Proteins were sedimented by centrifuga-
tion at 9000g for 1 min. 100 ll of supernatant was used for GSH
measurement by the method of Tietze [15].
2.7. Assay for GSH peroxidase (GPx), GSH reductase (GR), catalase, and
SOD activities
Assay kits for GPx, catalase, and SOD were purchased from OXIS
International Inc. (OR, USA). Enzyme activities and standard curves
were determined according to the manufacturer’s protocol. GR
activity was measured as described previously [16]. Brieﬂy,
150 ll of assay mixture containing 50 mM potassium phosphate
buffer (pH 7.6), 1 mM EDTA, 0.1 mM NADPH, and 1 mM GSSG
was mixed with 200 ll of cellular homogenate. This mixture was
incubated at 25 C for 5 min and absorbance at 340 nm was
measured.
2.8. Immunocytochemistry
Cells were ﬁxed with 70% methanol in PBS and permeabilized
with 0.1% Triton X-100. After blocking with 3% bovine serum albu-
min in PBS, the cells were incubated with anti-Trx antibody for 2 h
at room temperature. The cells were stained with secondary anti-
body conjugated with ﬂuorescein isothiocyanate (FITC) and 40-6-
diamidino-2-phenylindole (DAPI) for nuclear staining, and viewed
under a Nikon E800 microscope equipped with a cooled CCD
camera.
2.9. Statistical analysis
All data are presented as means ± S.D. from three independent
experiments. Statistical comparison between different treatments
was done using Student’s t-test. Differences with P value less than
0.05 were considered statistically signiﬁcant.
3. Results
3.1. ADM inhibits necrotic cell death induced by O2 deprivation
H/R can trigger necrotic as well as apoptotic cell death, depend-
ing on degree of severity of hypoxia or cellular status including ATP
levels [17,18]. Initially, in an attempt to delineate the nature of cell
death in our H/R experimental system, we characterized cell death
based on characteristic morphology and membrane integrity. A549
cells exposed to hypoxia for 12 h, followed by 6 h of reoxygenation,
died with cellular swelling and nuclear shrinkage (Fig. 1A). In addi-
tion, approximately an eight-fold increase of LDH release into cul-
ture medium was detected (Fig. 1B). In contrast, caspase-3 activity
was not signiﬁcantly altered (data not shown), suggesting that H/
R-induced necrosis in A549 cells. ADM exerts its multifunctional
Fig. 1. ADM protects against necrotic cell death induced by O2 deprivation. A549 cells were exposed to normoxia or 0.2% hypoxia for 12 h, followed by 6 h of reoxygenation in
the presence or absence of 103 lM or the indicated concentration of ADM with or without ADMA (2 lM). ADM and ADMA were treated for 48 h before the cell harvest. (A)
Morphologic appearance of A549 cells. (B) Assay for LDH release. The amount of released LDH was expressed as percent of total activity in each sample as compared to
normoxic cells. **P < 0.01. (C) Expression of mRNA and protein of CRLR in A549 cells. mRNA and protein were extracted from A549 and HUVEC cells, and PCR (upper panel)
and Western blot (lower panel) were performed as described in methods. HUVEC cells were used for the positive control. (D) Cell death rates were assessed by trypan blue
exclusion method. N, normoxia. **P < 0.01. Data represent the means ± S.D. of three independent experiments.
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whether CRLR is expressed in A549 cells prior to the evaluation
of ADM effects on A549 cells. As shown in Fig. 1C, mRNA of CRLR
and its translational product were expressed in A549 cells. Next,
we evaluated whether ADM has any protective effects on H/R-in-
duced cell death. Interestingly, ADM blocked cellular morphologic
changes as well as leakage of LDH against H/R injury (Fig. 1 A and
B). In addition, these protective functions against H/R injury were
dose- and receptor-dependent since the partial ADM peptide act-
ing as an antagonist (ADMA) suppressed the effect of ADM (Fig. 1
B and D). Collectively, our results indicate that ADM inhibited
necrotic cell death triggered by H/R.
3.2. ADM attenuates cellular ROS increase induced by H/R or hydrogen
peroxide
Since ROS is a key mediator in H/R injury, our results above led
us to examine whether ADM affects ROS levels during H/R injury.
A549 cells were exposed to hypoxia for 12 h, followed by 6 h of
reoxygenation in the presence or absence of 103 lM ADM, and
ROS levels were determined using DCF-DA ﬂuorescent dye. Treat-
ment of cells with ADM attenuated the ROS increase generated
by H/R (Fig. 2A). Next, we assessed whether this ROS attenuation
was observed in oxidative stress, like that caused by exogenous
hydrogen peroxide. A549 cells were treated with 100 lM hydrogen
peroxide in the presence or absence 102 lM ADM. As shown in
Fig. 2B, ADM inhibited ROS increase induced by hydrogen peroxide.
Our data indicate that ADM effectively suppressed ROS increase in-
duced by H/R or exogenous oxidative stress.
3.3. ADM maintains cellular GSH level against H/R
GSH is the most abundant low molecular weight thiol inside
mammalian cells, and changes in GSH level directly reﬂect intra-
cellular redox alterations [19]. Therefore, we examined whether
ROS attenuation driven by ADM is associated with GSH level.
A549 cells were exposed to hypoxia for the indicated times, fol-
lowed by 6 h of reoxygenation with or without 103 lM ADM,
and GSH concentration was determined. GSH concentration wasreduced after H/R in a time-dependent manner (Fig. 3A). In con-
trast, GSH level was well maintained almost to the level of norm-
oxic conditions in the presence of ADM (*P < 0.05) (Fig. 3A). GSH
is present in reduced (GSH) and oxidized (GSSG) forms [20]. Under
physiological conditions the level of the reduced form of GSH is 10-
to 100-fold higher than the oxidized form [21]. GSSG can be cata-
lytically reduced back to GSH or vice versa by the NADPH-depen-
dent glutathione reductase (GR) and glutathione peroxidase
(GPx) systems [20], respectively. We next examined whether
ADM affects the enzyme activities of GPx and GR in H/R injury.
A549 cells were exposed to H/R with or without 103 lM ADM,
and GPx and GR activities were assayed. As shown in Fig. 3 B and
C, GPx and GR activities were maintained in ADM-treated cells at
89% and 85% the levels of normoxic cells, respectively, while their
activities were decreased to 36% and 51% of the levels in normoxic
cells, respectively, in ADM-untreated cells (*P < 0.05). To identify
the involvement of other ROS scavenger systems, activities of cat-
alase and SOD were determined. However, the activities of catalase
and SOD were not signiﬁcantly altered (data not shown). Our data
indicate that ADM inhibited decrease of GSH induced by H/R and
activated GPx and GR, key enzymes involved in redox regulation
of GSH.
3.4. ADM modulates expression of Trx and thioredoxin reductase
(TrxR)
In addition to the GSH system, Trx is also a key component of
the antioxidant defense system that protects cells against ROS.
We therefore measured the cellular levels of Trx and TrxR, which
maintains Trx in its active reduced form in the presence of NADPH
[22]. Cells were exposed to normoxia or hypoxia for the indicated
times, followed by 6 h of reoxygenation with or without 103 lM
ADM, and Western blots were used to determine Trx and TrxR
expression levels. Total Trx and TrxR expression levels were signif-
icantly decreased with H/R injury in a time-dependent manner
(Fig. 4A, left panel). However, they were well maintained in cells
co-treated with ADM (Fig. 4A, right panel). Again, we examined
the effects of ADM on Trx and TrxR expressions in oxidative stress
using hydrogen peroxide, since it has been reported that hydrogen
Fig. 2. ADM attenuates ROS increases induced by H/R or hydrogen peroxide. (A)
A549 cells were exposed to normoxia or hypoxia for 12 h, followed by 6 h of
reoxygenation with or without 103 lM ADM. ROS levels were determined using
DCF-DA ﬂuorescence dye by ﬂow cytometry. (B) A549 cells were treated with
100 lM H2O2 for 3 h in the presence or absence of 102 lM ADM. ROS levels are
identiﬁed as in ‘A’. The representative data of three independent experiments are
shown.
Fig. 3. ADMmaintains glutathione level against H/R. (A) A549 cells were exposed to
hypoxia for the indicated times, followed by 6 h of reoxygenation, and then total
glutathione contents were determined. Cells exposed to hypoxia for 12 h, followed
by 6 h of reoxygenation with or without 103 lM ADM, followed by determination
of GPx (B) or GR (C) activity. GPx or GR activity is presented as percent decrease
compared to normoxia. *P < 0.05. Data represent the means ± S.D. of three
independent experiments.
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hydrogen peroxide in the presence or absence of 102 lM ADM.
Consistent with H/R injury, ADM inhibited decrease of Trx or TrxR
expression in oxidative stress (Fig. 4B). Our data indicate that ADM
maintains Trx and TrxR expression levels in H/R injury or hydrogen
peroxide.
3.5. ADM determines the redox status of Trx
Trx is predominantly in its reduced status in cells under physi-
ological conditions, but is converted to the oxidized form when ex-
posed to oxidants [24]. Data above showed that ADM maintained
expression levels of Trx and TrxR under oxidative stress. Therefore,
we hypothesized that ADM may maintain Trx in an active reduced
form under H/R. To validate this hypothesis, we performed redox
Western blots to Trx. Redox westen blot analysis of the cells ex-
posed to H/R revealed the presence of a band with lower electro-
phoretic mobility than those observed in normoxia-exposed cells
(Fig. 5A). This band represents a two-disulﬁde form of Trx that con-
tains a non-active site disulﬁde in a region proximal to the active
site [13]. This oxidized form of Trx increased in proportion to time
of exposure to hypoxia, while treatment with ADM inhibited con-
version of Trx from the reduced to oxidized form (P < 0.05)(Fig. 5B). Cytoplasmic Trx translocates to the nucleus in response
to various stimuli such as UV and oxidative stress, although its bio-
logical signiﬁcance has not been clearly determined [13]. Since
ADM maintained Trx in its active reduced form, it may inhibit
translocation of Trx to the nucleus. To elucidate the effects of
ADM on Trx translocation, we exposed A549 cells to H/R in the
presence or absence of ADM and investigated nuclear transloca-
tion. H/R-induced nuclear translocation of Trx, which was sup-
pressed by ADM (Fig. 5C). Collectively, our data show that ADM
maintains the redox status of Trx and inhibits its nuclear transloca-
tion against H/R.
4. Discussion
We performed this study to explore the molecular mechanisms
of ADM that protect against H/R-induced cell death. H/R is the most
common cause of cell injury, with pathological implications in dis-
eases processes including stroke, myocardial infarction, and acute
alveolar injury. While hypoxic signalling pathways are composed
of complicated networks of the various gene products, ROS play a
central role in cell injury and death. Therefore we focused on ROS
and its central scavenging systems, GSH and Trx, in exploring the
Fig. 4. ADMmaintains Trx and TrxR levels against H/R. (A) Cells were exposed to H/
R as above in the presence or absence of 103 lM ADM. Thirty micrograms of
extracted protein was separated by SDS–PAGE and immunoblotted using anti-Trx,
anti-TrxR, or anti-tubulin antibody. (B) Cells were treated with 100 lMH2O2 for the
indicated times in the presence or absence of 102 lM ADM. Immunoblots were
performed as in ‘A’. The representative blot of three independent experiments is
shown.
Fig. 5. ADM maintains thioredoxin redox status. (A) Cells were exposed to H/R as
above in the presence or absence of 103 lM ADM. Representative redox western
blots against Trx are shown. (B) Relative ratio of oxidized Trx to total Trx was
determined using densitometry. *P < 0.05; **P < 0.01. N, normoxia. Data represent
the means ± S.D. of three independent experiments. (C) Cells were exposed to
normoxia or H/R in the presence or absence of 103 lMADM. Immunocytochemical
staining using anti-Trx antibody were performed and visualized using ﬂuorescence
microscopy.
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human adenocarcinoma cells of the lung because the epithelial cells
of the lung are the frequent victims of H/R in a variety of pulmonary
pathologic conditions.
ADM is up-regulated by hypoxia via hypoxia-inducible factor-1
a (HIF-1a), a master transactivator in response to hypoxia [25],
and participates in various survival signalling pathways [26]. Our
initial data clearly showed that ADM protected against H/R injury
in concentration-dependent manner in the range of 101 to
105 lM (Fig. 1D). In next results, however, we showed data using
103 lM of ADM because it was more physiological concentration
than 101 lM of ADM. H/R may induce apoptotic or necrotic cell
death, depending on severity of injury or status of cells [27]. In
our experimental system, cells underwent necrosis based on mor-
phology, LDH release, and caspase-3 assay (Fig. 1 and data not
shown). Previously, it has been reported that ADM inhibited hyp-
oxic cell death by upregulation of anti-death protein Bcl-2 [6].
However, this is not the case in our experimental system because
we could not ﬁnd upregulation of Bcl-2 (data not shown). These re-
sults prompted us to examine the effects of ADM on ROS level in H/
R or exogenous oxidative stress. Cellular ROS levels are tightly reg-
ulated by the balances between generation and degradation by
anti-oxidant defense systems. Our data on ROS attenuation by
ADM support the degradation of free radicals by activation of scav-
enger systems, because ADM suppressed ROS increase from oxida-
tive stress by exogenous hydrogen peroxide (Fig. 2B). Cells possess
various complex antioxidant defense systems including non-enzy-
matic antioxidants (e.g., GSH and Trx) as well as enzymatic activi-
ties (e.g., catalase and SOD) [28]. Our next experiments focused on
identiﬁcation of antioxidants modulated by ADM. Fig. 3 revealed
that ADM maintained GSH level in H/R almost to the levels of nor-
moxia. GSH plays an important role in preserving membrane integ-
rity and in assuring the reduced state of the protein thiol group.
Therefore, deletion of GSH provokes cellular damage [29]. GSH is
present as a reduced form (GSH) and two oxidized species: gluta-
thione disulﬁde (GSSG) and glutathione mixed disulﬁde with pro-
tein thiols (GS-R) [20]. Under physiological conditions the reduced
form of GSH is 10- to 100-fold more common than the oxidized
form, but the ratio is decreased by oxidative stress [21]. The redox
status of GSH is controlled by GPx and GR, which catalytically con-
vert GSH from the reduced to the oxidized form or vice versa,
respectively [20]. Our results indicated that ADM maintained both
enzyme levels to normoxia. Collectively, our data suggest that
ADM participates in GSH redox pathway by modulation of GPx
and GP.
Although the precise mechanisms by which ADM regulates re-
dox systems and candidate molecules responsible for it have not
yet been clariﬁed, we have shown previously that ADM elevated
cellular GSH levels via an up-regulation of its rate-limiting syn-
thetic enzyme, c-glutamate-cysteine ligase (c-GCL) [30]. This ﬁnd-
ing suggests that c-GCL and its downstream proteins may be the
candidate molecules that link ADM with redox regulation systems.
However, there are several reports showing that ADM suppresses
ROS production through different signalling pathways, such as
the activation of the cAMP-protein kinase A pathway in mesangial
cells [31] and the inhibition of nicotinamide adenine dinucleotide
phosphate oxidase via the nitric oxide-cGMP signalling pathway
[32].
Trx is the major cellular protein disulﬁde reductase with thiol/
disulﬁde active site (Cys-Gly-Pro-Cys) [33]. It is induced by a vari-
ety of oxidative stimuli, including UV irradiation, inﬂammatory
cytokines, and chemical carcinogens [34]. Decreased levels of total
or reduced Trx are associated with various pathological states,
including apoptosis and oxidative stress [22]. Although expression
of Trx is regulated by a variety of regulatory proteins [34], ﬂavoen-
zyme TrxR is a key enzyme that maintains Trx in its active reduced
218 S.-M. Kim et al. / FEBS Letters 584 (2010) 213–218form [35]. We showed that ADM maintained the active reduced
form as well as total Trx levels against H/R (Figs. 4 and 5). Oxida-
tive stresses induce redistribution of Trx from the cytoplasmic
compartment to the nucleus, where it participates in regulation
of a variety of redox-sensitive transcriptional factors like NF-jB
and AP1 [13,36]. ADMmaintained Trx in a reduced status as shown
in Fig. 5, which may be a possible mechanism by which ADM inhib-
its nuclear translocation of Trx.
In conclusion, we showed that ADM suppressed increase of ROS
levels by modulation of GSH and Trx thiol redox systems. Our data
strongly suggest that this is the mechanism by which ADM pro-
tects against oxidative stress such as H/R.
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